Bujkiewicz, S; Jones, HE; Lai, MC; Cooper, NJ; Hawkins, N; Squires, H; Abrams, KR; Spiegelhalter, DJ; Sutton, AJ; (2011) Development of a transparent interactive decision interrogator to facilitate the decision-making process in health care. Value in health, 14 (5). pp. 768-76. ISSN 1098-3015 DOI: https://doi.org/10.1016/j.jval.2010.12.002

Hinks, A; Moncrieffe, H; Martin, P; Ursu, S; Lal, S; Kassoumeri, L; Weiler, T; Glass, DN; Thompson, SD; Wedderburn, LR; (2011) Association of the 5-aminoimidazole-4-carboxamide ribonucleotide transformylase gene with response to methotrexate in juvenile idiopathic arthritis. Annals of the rheumatic diseases, 70 (8). pp. 1395-1400. ISSN 0003-4967 DOI: https://doi.org/10.1136/ard.2010.146191

Bjorkman, L; Raynes, JG; Shah, C; Karlsson, A; Dahlgren, C; Bylund, J; (2010) The Proinflammatory Activity of Recombinant Serum Amyloid A Is Not Shared by the Endogenous Protein in the Circulation. Arthritis and rheumatism, 62 (6). pp. 1660-1665. ISSN 0004-3591 DOI: https://doi.org/10.1002/art.27440 Full text not available from this repository.

Bravo Vergel, Y; Hawkins, NS; Claxton, K; Asseburg, C; Palmer, S; Woolacott, N; Bruce, IN; Sculpher, MJ; (2007) The cost-effectiveness of etanercept and infliximab for the treatment of patients with psoriatic arthritis. Rheumatology (Oxford, England), 46. pp. 1729-35. ISSN 1462-0324 DOI: https://doi.org/10.1093/rheumatology/kem221 Full text not available from this repository.

Woolacott, N; Bravo Vergel, Y; Hawkins, N; Kainth, A; Khadjesari, Z; Misso, K; Light, K; Asseburg, C; Palmer, S; Claxton, K; +3 more... Bruce, I; Sculpher, M; Riemsma, R; (2006) Etanercept and infliximab for the treatment of psoriatic arthritis: a systematic review and economic evaluation. Health technology assessment (Winchester, England), 10. iii-iv, xiii-xvi, 1-239. ISSN 1366-5278 https://researchonline.lshtm.ac.uk/id/eprint/2534859